Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Prostate-specific antigen velocity (PSAV) and PSAV per initial volume (PSAVD) for early detection of prostate cancer in Chinese men.

Zheng XY, Zhang P, Xie LP, You QH, Cai BS, Qin J.

Asian Pac J Cancer Prev. 2012;13(11):5529-33.

2.

The role of prostate-specific antigen velocity in prostate cancer early detection.

Potter SR, Carter HB.

Curr Urol Rep. 2000 May;1(1):15-9. Review.

PMID:
12084336
4.

Clinical Utility of Biomarkers in Localized Prostate Cancer.

Leapman MS, Nguyen HG, Cooperberg MR.

Curr Oncol Rep. 2016 May;18(5):30. doi: 10.1007/s11912-016-0513-1. Review.

5.

Circulating biomarkers for prostate cancer.

Steuber T, Helo P, Lilja H.

World J Urol. 2007 Apr;25(2):111-9. Epub 2007 Mar 8. Review.

PMID:
17345087
6.

PSAD Test in the Diagnosis of Prostate Cancer: a Meta-Analysis.

Feng ZJ, Xue C, Wen JM, Li Y, Wang M, Zhang N.

Clin Lab. 2017 Jan 1;63(1):147-155. doi: 10.7754/Clin.Lab.2016.160727. Review.

7.

Virus encoded circulatory miRNAs for early detection of prostate cancer.

Kim J, Yun SJ, Kim WJ.

BMC Urol. 2015 Nov 26;15:116. doi: 10.1186/s12894-015-0111-9. Review.

8.

[MOLECULAR MARKERS FOR PROSTATE CANCER].

Engelstein D.

Harefuah. 2017 May;156(5):318-321. Review. Hebrew.

PMID:
28551905

Supplemental Content

Support Center